XML 42 R29.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

12 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows:

			Weighted Average Remaining Vesting		Weighted Average Per Share		Weighted- average Per Share
			Life		Intrinsic		Grant Date
	Shares		(In years)		Value		Fair Value
Unvested or unlapsed shares at January 31, 2014		101,296		1.5		-	$	4.10
Granted		-		-		-		-
Vested/lapsed		(10,555)		-		-		-
Forfeited		-		-		-		-
Unvested or unlapsed shares, beginning of period at March 31, 2014		90,741		1.3	$	-	$	4.10
Granted		-		-		-		-
Vested / lapsed		(78,519)		-		-		-
Forfeited		-		-		-		-
Unvested or unlapsed shares at March 31, 2015		12,222		0.3	$	0. 50	$	4.10

Stock Option Transactions Under Stock Option Plans

Stock option activity is summarized below:

	Shares		Weighted Average Per Share Exercise Price		Weighted Average Remaining Life (Years)		Weighted Average Per Share Intrinsic Value
Balance, January 31, 2014		735,800	$	1.70		9.0	$	1.60
Granted		-		-		-		-
Cancelled		(88,767)		2.30		7.9		-
Exercised		-		-		-		-
Expired		-		-		-		-
Forfeited		(18,333)		2.10		8.5		-
Balance, March 31, 2014		628,700	$	2.00		8.7	$	1.10
Granted		162,000		10.00		-		-
Cancelled		(14,200)		-		-		-
Exercised		-		-		-		-
Expired		-		-		-		-
Forfeited		-		-		-		-
Balance, March 31, 2015		776,500	$	4.69		7.4	$	1.50
Vested and exercisable, March 31, 2015		658,306	$	2.20		5.1	$	2.40

Summary of Restricted Stock Award

The following table summarizes the restricted stock award in the ACO Plan:

	Shares		Weighted Average Remaining Vesting Life (Years)		Weighted Average Per Share Intrinsic Value		Weighted Average Per Share Fair Value
Balance, January 31, 2014		3,752,000		1.0	$	0.02	$	0.03
Granted		-		-		-		-
Released		-		-		-		-
Balance, March 31, 2014		3,752,000		0.8	$	0.02	$	0.03
Granted		184,000		-		-		0.77
Released		(183,996)		-		-		-
Balance, March 31, 2015		3,752,004		0.1	$	0.70	$	0.07
Vested and exercisable, March 31, 2015		3,651,675

Total Unrecognized Compensation Costs Related To Non-Vested Stock-Based Compensation Arrangements

As of March 31, 2015, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under the Company’s 2010 and 2013 Equity Plans, and the ACO Plan’s are as follows:

Common stock options	$	246,834
Restricted stock	$	72,440
ACO Plan restricted stock	$	27,720

Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards

Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying consolidated statement of operations as follows:

	Year Ended March 31, 2015		Two Months Ended March 31, 2014		Year Ended January 31, 2014
Stock-based compensation expense:
Cost of services	$	13,376	$	15,703	$	616,902
General and administrative		1,245,472		44,484		1,540,955
	$	1,258,848	$	60,187	$	2,157,857

Warrants Outstanding

Warrants consisted of the following:

	Weighted Average Per Share
	Intrinsic		Number of
	Value		Warrants
Outstanding at January 31, 2014	$	0.40		314,500
Granted		-		400,000
Exercised		-		-
Cancelled		-		-
Outstanding at March 31, 2014		0.20		714,500
Granted		-		200,000
Exercised		-		-
Cancelled		-		-
Outstanding at March 31, 2015	$	0.46		914,500

				Weighted				Weighted
				average				average
Exercise Price Per		Warrants		remaining		Warrants		exercise price per
Share		outstanding		contractual life		exercisable		share
$	1.15		125,000		1.3		125,000	$	1.15

$	1.15		25,000		1.3		25,000	$	1.15

$	4.50		50,000		1.3		50,000	$	4.50

$	5.00		10,000		2.6		10,000	$	5.00

$	4.50		82,500		2.8		82,500	$	4.50

$	4.00		22,000		2.8		22,000	$	4.00

$	10.00		200,000		6.0		-	$	10.00

$	20.00		200,000		6.0		-	$	20.00

$	10.00		100,000		6.0		-	$	10.00

$	10.00		100,000		3.3		100,000	$	10.00
			914,500		4.3		414,500	$	4.60

Amount of Shares of Common Stock Reserved

The amount of shares of common stock reserved for these purposes is as follows at March 31, 2015:

Common stock issued and outstanding		4,863,389
Conversion of 9% Notes		275,000
Conversion of 8% Notes		200,000
Warrants outstanding		914,500
Stock options outstanding		776,500
Remaining shares issuable under 2013 Equity Incentive Plan		90,000
		7,119,389

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details